Softwr

Research · head to head

Attest vs Dotmatics

Attest logo

Attest

Research

Straightforward pricing for predictable research costs

From
On request
Rated
-
Full reviewWebsite
Dotmatics logo

Dotmatics

Research

Research informatics group behind GraphPad Prism, SnapGene, Geneious and LabArchives, now owned by Siemens

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Attest pricing is metered by credits, where one credit equals one survey question answered by one person, rather than a flat per seat rate; Dotmatics the portfolio was assembled by acquisition and integration between the constituent products is uneven, so buying several Dotmatics brands does not deliver a single connected environment and often means the same manual export steps as before.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Attest and Dotmatics actually diverge.

Attributes where Attest and Dotmatics differ
AttributeAttestDotmatics
Pricing modelsubscriptionquote
PlatformsWebWeb, Windows, macOS, On-premise

Identical on both: starting price (On request), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Attest

Nothing recorded that Dotmatics does not also cover.

Only in Dotmatics

  • Dotmatics platform
  • GraphPad Prism
  • SnapGene
  • Geneious Prime and Biologics
  • LabArchives
  • Flow cytometry tools
  • Protein Metrics
  • Siemens ownership

What people use each for

The jobs each tool is most often brought in to do.

Attest

  • Testing product concepts with global audiencesnot Dotmatics
  • Monitoring brand health across campaignsnot Dotmatics
  • Validating creative concepts before launchnot Dotmatics
  • Researching market trends in 70 languagesnot Dotmatics

Dotmatics

  • A pharmaceutical company consolidating compound registration, assay data and biology screening onto one informatics layernot Attest
  • A biotech that already owns Prism, SnapGene and Geneious separately and wants to understand what a group contract would covernot Attest
  • A university licensing LabArchives across departments as an institutional electronic lab notebooknot Attest
  • A biologics group needing sequence analysis, flow cytometry and proteomics tools from one supplier with a single procurement routenot Attest

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Attest

  • Pricing is metered by credits, where one credit equals one survey question answered by one person, rather than a flat per seat rate
  • The Basic tier caps usage at 50,000 credits; going beyond it requires upgrading to Standard (100,000), Elite (200,000) or a custom plan above 400,000
  • Additional credits purchased mid year cost 10 percent more per credit than the plan rate

Dotmatics

  • The portfolio was assembled by acquisition and integration between the constituent products is uneven, so buying several Dotmatics brands does not deliver a single connected environment and often means the same manual export steps as before.
  • The Siemens acquisition completed in July 2025 with stated revenue synergy targets, which usually translates into pressure to move individually bought desktop licences into larger platform agreements, and small buyers of a single Prism or SnapGene seat should expect that pressure at renewal.
  • Nothing about the enterprise platform is publicly priced, and even the individual applications are increasingly moved to subscription, so total cost across a research group is hard to establish before negotiation.
  • Each acquired product retains its own licence terms, support channel and release cycle, so an organisation using four Dotmatics brands manages four different renewal dates, entitlement models and support experiences.
  • Enterprise deployments require data migration and configuration services, and validated instances for regulated use add both cost and an ongoing customer revalidation duty after each release, so the informatics platform is a programme rather than a purchase.

Pricing, plan by plan

Attest

On request
  • Basic$undefined/mo
    • Up to 50,000 credits
  • Standard$undefined/mo
    • Up to 100,000 credits
  • Elite$undefined/mo
    • Up to 200,000 credits
  • Custom$undefined/mo
    • Over 400,000+ credits

Dotmatics

On request
  • Dotmatics platform$undefined/year
    • Enterprise informatics platform priced per user per year on quotation
    • Chemistry and biology registration, assay data and ELN modules scoped separately
    • Implementation and data migration services quoted as a separate programme

Which should you pick?

Choose Attest if

Nothing in the data separates Attest from Dotmatics on the points above - pick on price and on how each one feels to use.

Attest review

Choose Dotmatics if

  • You need dotmatics platform.
  • You work on Web, Windows, macOS, On-premise.
  • You also want graphpad prism.
Dotmatics review

Questions people ask

Is Attest or Dotmatics better?
Neither clearly leads. Attest starts at On request and Dotmatics at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Attest or Dotmatics?
Attest starts at On request and Dotmatics at On request.
Does Attest or Dotmatics run on more platforms?
Attest runs on Web. Dotmatics runs on Web, Windows, macOS, On-premise.
What is Attest best used for?
Attest is most often used for testing product concepts with global audiences, monitoring brand health across campaigns, validating creative concepts before launch, researching market trends in 70 languages. Of those, testing product concepts with global audiences and monitoring brand health across campaigns are not what Dotmatics is typically brought in for.
What can Attest do that Dotmatics cannot?
Dotmatics covers Dotmatics platform, GraphPad Prism, SnapGene, Geneious Prime and Biologics.

Answered from the vendors’ own pages

Attest: How does Attest's credit system work?

Attest uses a credit-based pricing system where one credit equals one survey answer from one respondent. For example, a 10-question survey completed by 500 people uses 5,000 credits. Only respondents who meet survey criteria consume credits from the qualifying question.

Source
Dotmatics: Who owns Dotmatics?

Siemens, which completed a 5.1 billion dollar acquisition on 1 July 2025. Dotmatics now sits inside Siemens Digital Industries Software.

Attest: What plans does Attest offer?

Attest offers four subscription plans: Basic (up to 50,000 credits), Standard (up to 100,000 credits), Elite (up to 200,000 credits), and Custom (over 400,000+ credits). All plans include unlimited user seats, designated research expert, customer success team support, and access to 150+ million consumers across 59 countries in 70+ languages.

Source
Dotmatics: Is GraphPad Prism a Dotmatics product?

Yes. So are SnapGene, Geneious, LabArchives, FCS Express, OMIQ, Protein Metrics, SoftGenetics and nQuery.

Attest: Can I purchase additional credits on Attest?

Yes. Additional credits are available as add-ons throughout the year. Add-on credits cost 10% more than the per-credit rate in annual plans.

Source
Dotmatics: Do the products work together?

To varying degrees. They were acquired separately and integration across the portfolio is uneven, so verify the specific pair you care about before assuming it.

Dotmatics: Is enterprise pricing published?

No. The informatics platform is quoted per user per year with modules and services scoped separately.

Share

Related pages

More on Attest

More on Dotmatics

Keep looking

Other head to heads